Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMMERCE BANCSHARES INC /MO/CBSH · Entity 3630 | Director | May 29, 2026 | June 02, 2026 |
| Snap-on IncSNA · Entity 3268 | Director | February 12, 2026 | February 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMMERCE BANCSHARES INC /MO/
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,305 |
Reported balance
After 2026-05-29 transaction · row 1
1 source rowRow 1 · 2026-05-29 · Grant · Acquired 886 · Balance 20,305 |
Snap-on Inc
Report date February 12, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,550 |
Reported balance
After 2026-02-12 transaction · row 1
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 520 · Balance 8,550 F1: Grant of restricted stock from the Company. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,607 |
Reported balance
Holding disclosure · report date 2026-02-12 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 9,607 F2: 1 for 1. F3: All restrictions lapse upon the earliest of retirement from the Board, death or a change in control; the reporting person will receive the underlying shares upon the earliest of the reporting person's 70th birthday if the reporting person leaves the Board before that time (in which case she will receive them in one lump sum or five equal annual installments depending on the applicable deferral election), death or a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock from the Company.
F2: 1 for 1.
F3: All restrictions lapse upon the earliest of retirement from the Board, death or a change in control; the reporting person will receive the underlying shares upon the earliest of the reporting person's 70th birthday if the reporting person leaves the Board before that time (in which case she will receive them in one lump sum or five equal annual installments depending on the applicable deferral election), death or a change in control.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Livongo Health, Inc.
Report date October 30, 2020 · Filed October 30, 2020
Section 16 reporting ended · disclosed 2020-10-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-10-30 transaction · row 1
1 source rowRow 1 · 2020-10-30 · Disposition to issuer · Disposed 64,142 · Balance 0 F1: Includes 40,607 restricted stock units ("RSUs"). F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. ("Teladoc"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any). F3: Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions). F4: The "Equity Award Adjustment Ratio" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 40,607 restricted stock units ("RSUs").
F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. ("Teladoc"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any).
F3: Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions).
F4: The "Equity Award Adjustment Ratio" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020.
Teladoc Health, Inc.
Report date May 22, 2024 · Filed May 24, 2024
Section 16 reporting ended · disclosed 2024-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,995 |
Ending reported balance
After 2024-05-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-05-22 · Exercise / conversion · Acquired 9,834 · Balance 46,829 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2024-05-23 · Sale · Disposed 9,834 · Balance 36,995 F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 15, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-05-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-22 · Exercise / conversion · Disposed 9,834 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 15, 2023.
F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 23, 2021 21:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005437 · form4-11232021_011115.xml · derivative · entry 3 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 872 Underlying: Common Stock · 436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-005437 · form4-11232021_011115.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 17:57 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 14 | $70.51 | $987.14 |
DisclosureSEC source: 0001127602-21-028045 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,917 Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 20:43 UTC | Snap-on Inc SNA · Entity 3268 | SaleCommon Stock | 3,219 | $222.30 | $715,583.70 |
DisclosureSEC source: 0001127602-21-025145 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,378 Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008440 · edgar.xml · derivative · entry 2 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,462 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,462 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-008440 · edgar.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 19:49 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 191 | $70.73 | $13,509.43 |
DisclosureSEC source: 0001127602-21-022886 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,903 Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 715 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005968 · edgar.xml · derivative · entry 3 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005968 · edgar.xml · derivative · entry 2 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,462 Underlying: Common Stock · 6,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-005968 · edgar.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005485 · edgar.xml · derivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:51 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 173 | $77.81 | $13,461.13 |
DisclosureSEC source: 0001127602-21-015149 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,712 Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 20:37 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 183 | $74.03 | $13,547.49 |
DisclosureSEC source: 0001127602-21-008659 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,539 Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 713 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002338 · edgar.xml · derivative · entry 3 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715 Underlying: Common Stock · 713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002338 · edgar.xml · derivative · entry 2 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,922 Underlying: Common Stock · 6,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002338 · edgar.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 21:50 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-005893 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,597 F1 · price: Grant of restricted stock from the Company. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 18:16 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 762 | $65.70 | $50,063.40 |
DisclosureSEC source: 0001127602-21-000341 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,356 F1 · balance_after: All stock holding balances adjusted to include a 5% stock dividend. Record date 12/2/2020, payable 12/18/2020. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 713 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011461 · edgar.xml · derivative · entry 3 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 6,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011461 · edgar.xml · derivative · entry 2 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,382 Underlying: Common Stock · 6,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 21:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,173 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-011461 · edgar.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 19, 2020 Filed Nov 20, 2020 21:42 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011267 · edgar.xml · derivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 Underlying: Common Stock · 1,308 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021. F2 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021. Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 21:24 UTC | Livongo Health, Inc. LVGO · Entity 145566 | Disposition to issuerCommon Stock | 64,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001639225-20-000066 · wf-form4_160409308447282.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 40,607 restricted stock units ("RSUs"). F2 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 5, 2020, by and among the Issuer, Teladoc Health, Inc. ("Teladoc"), and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, each share of the Issuer's common stock was converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of fractional shares (if any). F3 · price: Pursuant to the Merger Agreement, each outstanding RSU award of the Issuer was converted into a number of RSUs with respect to a number of shares of Teladoc common stock equal to the product of (i) the number of shares of the Issuer's common stock subject to such RSU award immediately prior to the effective time of the merger and (ii) the Equity Award Adjustment Ratio (as defined below) (rounded down to the nearest whole share of Teladoc common stock on an award-by-award basis), subject to the same terms and conditions as were applicable to such Issuer RSU immediately prior to the effective time of the merger (including applicable vesting conditions). F4 · price: The "Equity Award Adjustment Ratio" means the quotient determined by dividing (i) the volume weighted average closing price of the Issuer's common stock on the four trading days ending on October 29, 2020 by (ii) the volume weighted average closing price of Teladoc common stock on the four trading days beginning on October 29, 2020. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 18:56 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 217 | $62.25 | $13,508.25 |
DisclosureSEC source: 0001127602-20-027937 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,376 Read SEC document |
| September 11, 2020 Filed Sep 11, 2020 21:59 UTC | Livongo Health, Inc. LVGO · Entity 145566 | SaleCommon Stock | 15,000 | $126.71 | $1,900,650.00 |
DisclosureSEC source: 0001639225-20-000021 · wf-form4_159986152699293.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,142 F1 · kind: Represents shares sold to cover withholding taxes due upon the vesting of restricted stock units on August 25, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:19 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 236 | $57.26 | $13,513.36 |
DisclosureSEC source: 0001127602-20-022693 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,159 Read SEC document |
| May 19, 2020 Filed May 29, 2020 22:33 UTC | Livongo Health, Inc. LVGO · Entity 145566 | GrantCommon Stock | 4,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033043 · doc4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,142 F1 · shares: The reported shares are represented by restricted stock units which vest in four equal quarterly installments beginning on August 25, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 19:17 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 220 | $61.19 | $13,461.80 |
DisclosureSEC source: 0001127602-20-015163 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,923 Read SEC document |
| February 29, 2020 Filed Mar 3, 2020 20:33 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 221 | $61.04 | $13,489.84 |
DisclosureSEC source: 0001127602-20-008896 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,703 Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:49 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005683 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,835 F1 · price: Grant of restricted stock from the Company. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:03 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 739 | $67.94 | $50,207.66 |
DisclosureSEC source: 0001127602-20-000794 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,482 F1 · balance_after: All stock holding balances adjusted to include a 5% stock dividend. Record date 12/3/19, payable 12/18/19. Read SEC document |
| November 30, 2019 Filed Dec 3, 2019 20:38 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 186 | $67.03 | $12,467.58 |
DisclosureSEC source: 0001127602-19-034108 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613 Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 20:47 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 16 | $64.36 | $1,029.76 |
DisclosureSEC source: 0001127602-19-031628 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,427 Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 20:07 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 236 | $57.07 | $13,468.52 |
DisclosureSEC source: 0001127602-19-027857 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,411 Read SEC document |
| April 30, 2019 Filed May 2, 2019 20:39 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 207 | $60.43 | $12,509.01 |
DisclosureSEC source: 0001127602-19-016968 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 21:41 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 16 | $62.93 | $1,006.88 |
DisclosureSEC source: 0001127602-19-009454 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,968 Read SEC document |
| February 14, 2019 Filed Feb 15, 2019 21:56 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 845 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006365 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,015 F1 · price: Grant of restricted stock from the Company. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 17:06 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 209 | $59.80 | $12,498.20 |
DisclosureSEC source: 0001127602-19-003633 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,952 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 20:18 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 889 | $56.37 | $50,112.93 |
DisclosureSEC source: 0001127602-19-000590 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,743 F1 · balance_after: All stock holding balances adjusted to include a 5% stock dividend. Record date 11/30/18, payable 12/17/18. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:24 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 212 | $63.60 | $13,483.20 |
DisclosureSEC source: 0001127602-18-031759 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814 Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 19:22 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 202 | $66.80 | $13,493.60 |
DisclosureSEC source: 0001127602-18-024230 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602 Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:16 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 383 | $63.52 | $24,328.16 |
DisclosureSEC source: 0001127602-18-015933 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:15 UTC | COMMERCE BANCSHARES INC /MO/ CBSH · Entity 3630 | GrantCommon Stock | 17 | $57.77 | $982.09 |
DisclosureSEC source: 0001127602-18-009587 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:32 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006734 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,170 F1 · price: Grant of restricted stock from the Company. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 21:01 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 30 | $157.78 | $4,733.40 |
DisclosureSEC source: 0001127602-17-030801 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,395 F1 · kind: Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 21:18 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 30 | $154.20 | $4,626.00 |
DisclosureSEC source: 0001127602-17-024767 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,365 F1 · kind: Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Read SEC document |
| April 28, 2017 Filed May 2, 2017 20:49 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 40 | $167.53 | $6,701.20 |
DisclosureSEC source: 0001127602-17-016357 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,335 F1 · kind: Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:44 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-005460 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,295 F1 · price: Grant of restricted stock from the Company. Read SEC document |
| January 31, 2017 Filed Feb 1, 2017 22:01 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 26 | $181.53 | $4,719.78 |
DisclosureSEC source: 0001127602-17-003371 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,521 F1 · kind: Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 20:54 UTC | Snap-on Inc SNA · Entity 3268 | GrantCommon Stock | 30 | $154.10 | $4,623.00 |
DisclosureSEC source: 0001127602-16-065684 · form4.xml · nonDerivative · entry 1 Daniel Karen L · CIK 0001346985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,495 F1 · kind: Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.